- Home
- PSNL
PSNL
Personalis Inc.
as 11-04-2025 3:45pm EST
Personalis Inc is a provider of genomic sequencing and analytics solutions to support the development of personalized cancer vaccines and other next-generation cancer immunotherapies. It has one segment, the sale of sequencing and data analysis services. Its products include ImmunoID NeXT, NeXT Personal, NeXT Dx Test, and other pharma research solutions.
| Founded: | 2011 | Country: | United States |
| Employees: | N/A | City: | FREMONT |
| Market Cap: | 854.8M | IPO Year: | 2019 |
| Target Price: | $8.70 | AVG Volume (30 days): | 1.3M |
| Analyst Decision: | Strong Buy | Number of Analysts: | 5 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -1.18 | EPS Growth: | N/A |
| 52 Week Low/High: | $2.83 - $10.95 | Next Earning Date: | 11-04-2025 |
| Revenue: | $80,317,000 | Revenue Growth: | 0.36% |
| Revenue Growth (this year): | -11.82% | Revenue Growth (next year): | 29.83% |
Latest Personalis Inc. News
PSNL Breaking Stock News: Dive into PSNL Ticker-Specific Updates for Smart Investing
GuruFocus.com
2 days ago
Earnings To Watch: Personalis Inc (PSNL) Reports Q3 2025 Result
Business Wire
14 days ago
Personalis to Announce Third Quarter 2025 Financial Results
Zacks
2 months ago
TEM Gains Validation for PurIST Amid Evolving Cancer Care Landscape
MT Newswires
2 months ago
Personalis Launches Breast Cancer Study with Yale Cancer Center
Business Wire
2 months ago
CATE Clinical Trial Launched to Demonstrate the Clinical Utility of ctDNA-Guided Treatment in Breast Cancer Using the Ultrasensitive NeXT Personal Test
Simply Wall St.
5 months ago
The 13% return this week takes Personalis' (NASDAQ:PSNL) shareholders one-year gains to 394%
Zacks
5 months ago
Personalis (PSNL) Soars 7.3%: Is Further Upside Left in the Stock?
Business Wire
5 months ago
Personalis’ NeXT Personal® Predicts Cervical Cancer Recurrence Risk in New CALLA Phase 3 Study Analysis Presented at ASCO
Compare PSNL vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "PSNL Personalis Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.